December 7, 2021 Speaker: Steve Smith, PhD

Approximately 7% -9% of the global population suffers from autoimmune diseases. World-wide drug sales for the treatment of autoimmune diseases were about $55.2 billion in 2019 and are predicted to reach $152.2 billion by 2025. Better animal models can enable better and faster preclinical research and development into new potential treatments for autoimmune diseases.
In this webinar, we will share with you:

• Mechanisms of human autoimmunity
• Mouse models for the study of autoimmune diseases
• Evaluation of drug efficacy and safety in autoimmune diseases using humanized mouse models

For more information, please contact sales@atlantisbioscience.com.sg

#Neurodegenerativedisease #Alzheimersdisease #animalmodels #drugdevelopment #translationalmedicine #KOAP #knockoutallproject #CrisprCas9 #genomeediting #knockout #conditionalknockout #mousemodel #metabolicdisease #autoimmunedisease #oncology #CART #CARNK #immunotherapy #immunodeficient

свернуть